跳至主要内容
临床试验/NCT02553733
NCT02553733已完成2 期

Effects of Dietary Nitrate Supplementation on Coronary Blood Flow and Walking Performance in Peripheral Arterial Disease

David N. Proctor, PhD1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2015年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
11
试验地点
1
主要终点
Exercise performance

研究概览

简要总结

In this study the investigators will test the hypothesis that short-term consumption of inorganic nitrate (supplied in concentrated beetroot juice) enhances coronary blood flow responses, large artery hemodynamics, and leg oxygenation/exercise tolerance in patients with peripheral arterial disease (PAD). Understanding and improving blood flow regulation in the heart and skeletal muscles of patients with PAD is important because exercise triggers symptoms of leg pain and substantially raises blood pressure and myocardial demand in these patients.

详细描述

Peripheral arterial disease (PAD) is a strong predictor of cardiovascular mortality and negatively affects functional capacity and quality of life for as many as 14 million patients in the U.S. alone. One open-label study showed that acute consumption of beetroot juice improved 6 min walk performance, reduced blood pressure, and enhanced leg muscle oxygenation in PAD patients. However, no studies have rigorously confirmed these findings in a double-blind manner, nor have the effects of this supplement been investigated (acutely or short-term) in the coronary circulation of PAD patients.

In addition to studying its effects on graded treadmill walking performance and consequent large artery vasodilation, the present study will examine the effects of short-term beetroot juice consumption (twice/day) on both coronary and leg vasodilator (graded calf flexion) and vasoconstrictor (isometric handgrip, voluntary apnea) responses in patients with PAD. Participants will randomly consume either nitrate-rich or nitrate-depleted beetroot juice with a 7 to 14 day wash-out period between. Effects of beetroot juice consumption on plasma nitrate, nitrite and methemoglobin will also be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with peripheral arterial disease (PAD)
  • Capable of giving informed consent
  • Men and women age 21- 85 years
  • Diagnosed with PAD (i.e., ankle-brachial index below 0.9)
  • Fontaine stage II or less - no pain while resting
  • Satisfactory history and physical exam

排除标准

  • Pregnant or nursing women
  • Patients taking nitroglycerine or nitrate preparations
  • Patients taking phosphodiesterase inhibitors such as sildenafil or tadalafil
  • Patients taking proton pump inhibitors
  • Ejection fraction < 40%
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Myocardial infarction within past 6 months or unstable angina
  • Severe lung disease (i.e., on supplemental oxygen or frequently use rescue inhalers)
  • Abnormality in hemoglobin or hematocrit or methemoglobin
  • Impaired renal function
  • Impaired liver function
  • History or diagnosis of Barrett's esophagus
  • Known allergy to beetroot juice or lemon juice
  • Inability to walk on a treadmill at a moderate pace (2.0 miles/hour)

研究组 & 干预措施

Beetroot juice (Beet-It Organic Shot)

Active Comparator

Subjects will consume 70 ml of beetroot juice (Beet-It Organic Shot) twice per day (morning, afternoon) for 5 to 7 days to assess the short term effects of this nitrate supplement on graded treadmill walking responses (day 4) and vasodilator/vasoconstrictor responses in the coronary and lower leg circulations (day 5 or 6 or 7). On both study visits, subjects will consume their morning dose 1 hour 45 min before experiments begin.

干预措施: Beetroot juice (Drug)

Placebo Comparator: Beetroot juice (Beet-It Organic Shot)

Placebo Comparator

Subjects will consume 70 ml of beetroot juice (Beet-It Organic Placebo) twice per day (morning, afternoon) for 5 to 7 days to assess the short term effects of this nitrate supplement on graded treadmill walking responses (day 4) and vasodilator/vasoconstrictor responses in the coronary and lower leg circulations (day 5 or 6 or 7). On both study visits, subjects will consume their morning dose 1 hour 45 min before experiments begin.

干预措施: Beetroot juice placebo (Drug)

结局指标

主要结局

Exercise performance

时间窗: 5 to 7 days after initiating daily ingestion of beetroot juice

Exercise capacity will be assessed using a graded treadmill walking test to peak exertion with expired gas analysis and determination of peak oxygen uptake, calf muscle oxygenation, blood pressure, claudication onset time, and peak walking time.

Peak Treadmill Time

时间窗: 4 to 6 days after initiating daily ingestion of beetroot juice

Peak treadmill time was determined using the Gardner treadmill protocol, measured as the number of seconds the participant was able to walk until they asked to stop the test due to leg fatigue.

次要结局

  • Coronary vascular function(4 days after initiating daily ingestion of beetroot juice)
  • Leg vascular function(4 days after initiating daily ingestion of beetroot juice)
  • Coronary Flow Velocity Response to Peak Plantar Flexion Exercise(4 days after initiating daily ingestion of beetroot juice)
  • Resting Blood Pressure(4 to 6 days after initiating daily ingestion of beetroot juice)

研究者

发起方
David N. Proctor, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

David N. Proctor, PhD

Professor of Kinesiology and Physiology

Penn State University

研究点 (1)

Loading locations...

相似试验